SCHEMBL8097229

SCHEMBL8097229

COC(=O)C1=C(C)NC(C)=C(C(=O)OCCc2ccccn2)C1c1cccc(F)c1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
HSD17B10 Q99714 5/20 0.50
CYP2C9 P11712 4/20 0.47
CYP1A2 P05177 4/20 0.47
ADORA3 P0DMS8 4/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C19 P33261 3/20 0.47
KMT2A Q03164 3/20 0.47
HIF1A Q16665 3/20 0.47
NR1I2 O75469 3/20 0.47
ABCB11 O95342 3/20 0.47
LMNA P02545 3/20 0.47
SCN1A P35498 3/20 0.47
SCN5A Q14524 3/20 0.47
SCN2A Q99250 3/20 0.47
SCN3A Q9NY46 3/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
TP53 P04637 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8084731 0.90 CACNA1C (0.46) KDM4EHSD17B10CYP2C9CYP1A2ADORA3
SCHEMBL8091377 0.88 SMN1; SMN2 (0.51) KDM4EHSD17B10KMT2AMEN1TP53
SCHEMBL8100065 0.88 TP53 (0.51) KDM4EHSD17B10TP53MAPTCASP1
SCHEMBL8099097 0.87 SMN1; SMN2 (0.52) KDM4EHSD17B10KMT2AMEN1TP53
SCHEMBL8913648 0.84 ADORA3 (0.52) KDM4EHSD17B10CYP2C9CYP1A2ADORA3
SCHEMBL13285115 0.81 CYP2C9 (0.67) KDM4EHSD17B10CYP2C9CYP1A2ADORA3
SCHEMBL7884089 0.81 NR1I2 (0.59) KDM4EHSD17B10CYP2C9CYP1A2ADORA3
SCHEMBL6945817 0.79 ALOX15 (0.51) KDM4EHSD17B10CYP2C9CYP1A2ADORA3
SCHEMBL27439079 0.79 CACNA1C (0.45) KDM4EHSD17B10CYP2C9CYP1A2ADORA3
SCHEMBL11683102 0.77 KDM4E (0.59) KDM4EHSD17B10CYP2C9CYP1A2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6066655-A FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, IN PARTICULAR AS CEREBRAL THERAPEUTICS BAYER AKTIENGESELLSCHAFT (DE) 2000-05-23 US disclosed
US-5731333-A LEARNING AND MEMORY ENHANCEMENT, ANTIDEPRESSANTS BAYER AKTIENGESELLSCHAFT (DE) 1998-03-24 US disclosed